Similar articles for PMID: 19116303

Year	Number of Results
1993	1
1994	2
1996	5
1997	5
1998	5
1999	2
2000	5
2001	3
2002	5
2003	4
2004	8
2005	6
2006	6
2007	14
2008	23
2009	39
2010	22
2011	25
2012	19
2013	21
2014	13
2015	6
2016	4
2017	6
2018	5
2019	6
2020	2
2021	10
2022	17
2023	3
2024	0

1

Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses.

Lynch MM, Cernetich-Ott A, Weidanz WP, Burns JM Jr. Lynch MM, et al. Clin Vaccine Immunol. 2009 Mar;16(3):293-302. doi: 10.1128/CVI.00230-08. Epub 2008 Dec 30. Clin Vaccine Immunol. 2009. PMID: 19116303 Free PMC article.

2

Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.

Burns JM Jr, Flaherty PR, Nanavati P, Weidanz WP. Burns JM Jr, et al. Infect Immun. 2004 Oct;72(10):5605-12. doi: 10.1128/IAI.72.10.5605-5612.2004. Infect Immun. 2004. PMID: 15385457 Free PMC article.

3

Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.

Burns JM Jr, Flaherty PR, Romero MM, Weidanz WP. Burns JM Jr, et al. Vaccine. 2003 May 16;21(17-18):1843-52. doi: 10.1016/s0264-410x(03)00026-4. Vaccine. 2003. PMID: 12706668

4

Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.

Yoshida S, Nagumo H, Yokomine T, Araki H, Suzuki A, Matsuoka H. Yoshida S, et al. PLoS One. 2010 Oct 28;5(10):e13727. doi: 10.1371/journal.pone.0013727. PLoS One. 2010. PMID: 21060850 Free PMC article.

5

CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.

Xu H, Hodder AN, Yan H, Crewther PE, Anders RF, Good MF. Xu H, et al. J Immunol. 2000 Jul 1;165(1):389-96. doi: 10.4049/jimmunol.165.1.389. J Immunol. 2000. PMID: 10861076

6

A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1₄₂ in a Prime/Boost Heterologous Immunization Regimen Partially Protects Aotus Monkeys against Blood-Stage Challenge.

Obaldia N 3rd, Stockelman MG, Otero W, Cockrill JA, Ganeshan H, Abot EN, Zhang J, Limbach K, Charoenvit Y, Doolan DL, Tang DC, Richie TL. Obaldia N 3rd, et al. Clin Vaccine Immunol. 2017 Apr 5;24(4):e00539-16. doi: 10.1128/CVI.00539-16. Print 2017 Apr. Clin Vaccine Immunol. 2017. PMID: 28179404 Free PMC article.

7

Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.

Biswas S, Spencer AJ, Forbes EK, Gilbert SC, Holder AA, Hill AV, Draper SJ. Biswas S, et al. J Immunol. 2012 May 15;188(10):5041-53. doi: 10.4049/jimmunol.1101106. Epub 2012 Apr 13. J Immunol. 2012. PMID: 22504652 Free PMC article.

8

A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.

Rainczuk A, Scorza T, Spithill TW, Smooker PM. Rainczuk A, et al. Infect Immun. 2004 Oct;72(10):5565-73. doi: 10.1128/IAI.72.10.5565-5573.2004. Infect Immun. 2004. PMID: 15385453 Free PMC article.

9

Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.

Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA. Singh S, et al. Infect Immun. 2006 Aug;74(8):4573-80. doi: 10.1128/IAI.01679-05. Infect Immun. 2006. PMID: 16861644 Free PMC article.

10

Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys.

Pichyangkul S, Tongtawe P, Kum-Arb U, Yongvanitchit K, Gettayacamin M, Hollingdale MR, Limsalakpetch A, Stewart VA, Lanar DE, Dutta S, Angov E, Ware LA, Bergmann-Leitner ES, House B, Voss G, Dubois MC, Cohen JD, Fukuda MM, Heppner DG, Miller RS. Pichyangkul S, et al. Vaccine. 2009 Dec 11;28(2):452-62. doi: 10.1016/j.vaccine.2009.10.022. Epub 2009 Oct 24. Vaccine. 2009. PMID: 19857448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

273 results

Results by year